Approaches to understanding and addressing treatment-resistant depression: A scoping review

Depression Research and Treatment

Volumn 2012, Issue , 2012, Pages

  Jenkins, Emily ^a   Goldner, Elliot M ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b SIMON FRASER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873158276     PISSN: 20901321     EISSN: 2090133X     Source Type: Journal    
DOI: 10.1155/2012/469680     Document Type: Review

References (43)

1. Greden J. F., The burden of disease for treatment-resistant depression. The Journal of Clinical Psychiatry 2001 62, supplement 16 26 31 2-s2.0-0034934419
2. Sackeim H. A., The definition and meaning of treatment-resistant depression. The Journal of Clinical Psychiatry 2001 62, supplement 16 10 17 2-s2.0-0034934926
3. Berlim M. T., Turecki G., Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods. Canadian Journal of Psychiatry 2007 52 1 46 54 2-s2.0-34248381347 (Pubitemid 46743497)
4. Berlim M. T., Turecki G., What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trials. European Neuropsychopharmacology 2007 17 11 696 707 2-s2.0-34548773850 10.1016/j.euroneuro.2007.03.009 (Pubitemid 47422400)
5. Fava M., Diagnosis and definition of treatment-resistant depression. Biological Psychiatry 2003 53 8 649 659 2-s2.0-0038147546 10.1016/S0006-3223(03) 00231-2 (Pubitemid 39658481)
6. Fava G. A., Fabbri S., Sonino N., Residual symptoms in depression: an emerging therapeutic target. Progress in Neuro-psychopharmacology and Biological Psychiatry 2002 26 6 1019 1027 2-s2.0-0036775049 10.1016/S0278-5846(02)00226-9 (Pubitemid 35256092)
7. Judd L. L., Akiskal H. S., Maser J. D., Zeller P. J., Endicott J., Coryell W., Paulus M. P., Kunovac J. L., Leon A. C., Mueller T. I., Rice J. A., Keller M. B., Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. Journal of Affective Disorders 1998 50 2-3 97 108 2-s2.0-0032171096 10.1016/S0165-0327(98) 00138-4 (Pubitemid 28551779)
8. Kennedy N., Paykel E. S., Residual symptoms at remission from depression: impact on long-term outcome. Journal of Affective Disorders 2004 80 2-3 135 144 2-s2.0-2342538933 10.1016/S0165-0327(03)00054-5 (Pubitemid 38597136)
9. Greenberg P., Corey-Lisle P. K., Birnbaum H., Marynchenko M., Claxton A., Economic implications of treatment-resistant depression among employees. Pharmacoeconomics 2004 22 6 363 373 2-s2.0-2342606503 10.2165/00019053- 200422060-00003 (Pubitemid 38609813)
10. Arksey H., O'Malley L., Scoping studies: towards a methodological framework. International Journal of Social Research Methodology: Theory and Practice 2005 8 1 19 32 2-s2.0-14644388070 10.1080/1364557032000119616 (Pubitemid 40322704)
11. Anderson I. M., Sarsfield A., Haddad P. M., Efficacy, safety and tolerability of quetiapine augmentation in treatment resistant depression: an open-label, pilot study. Journal of Affective Disorders 2009 117 1-2 116 119 2-s2.0-67650086542 10.1016/j.jad.2008.12.016
12. Carvalho A. F., Cavalcante J. L., Castelo M. S., Lima M. C. O., Augmentation strategies for treatment-resistant depression: a literature review. Journal of Clinical Pharmacy and Therapeutics 2007 32 5 415 428 2-s2.0-34548617702 10.1111/j.1365-2710.2007.00846.x (Pubitemid 47404283)
13. Lam R. W., Chan P., Wilkins-Ho M., Yatham L. N., Repetitive transcranial magnetic stimulation for treatment-resistant depression: a systematic review and metaanalysis. Canadian Journal of Psychiatry 2008 53 9 621 631 2-s2.0-54249088497
14. Kito S., Fujita K., Koga Y., Changes in regional cerebral blood flow after repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex in treatment-resistant depression. Journal of Neuropsychiatry and Clinical Neurosciences 2008 20 1 74 80 2-s2.0-39749199396 10.1176/appi.neuropsych.20.1.74 (Pubitemid 351295031)
15. Kito S., Fujita K., Koga Y., Regional cerebral blood flow changes after low-frequency transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in treatment-resistant depression. Neuropsychobiology 2008 58 1 29 36 2-s2.0-51049113219 10.1159/000154477
16. Kito S., Hasegawa T., Okayasu M., Therapeutic efficacy of transcranial magnetic stimulation in treatment-resistant depression: A three-dimensional stereotactic ROI template (3DSRT) study. Clinical Neurophysiology 2009 120 5, article no. e153 10.1016/j.clinph.2009.02.033
17. Kito S., Hasegawa T., Fujita K., Koga Y., Changes in hypothalamic- pituitary-thyroid axis following successful treatment with low-frequency right prefrontal transcranial magnetic stimulation in treatment-resistant depression. Psychiatry Research 2010 175 1-2 74 77 2-s2.0-72049125609 10.1016/j.psychres. 2008.10.002
18. Burke M. J., Husain M. M., Concomitant use of vagus nerve stimulation and electroconvulsive therapy for treatment-resistant depression. Journal of Ect 2006 22 3 218 222 2-s2.0-33748598720 10.1097/01.yct.0000230364.04240.52 (Pubitemid 44379379)
19. Sperling W., Kornhuber J., Wiltfang J., Bleich S., Combined VNS-rTMS treatment in a patient with therapy resistant depression. Pharmacopsychiatry 2007 40 1 39 40 2-s2.0-34147115587 10.1055/s-2006-958524 (Pubitemid 46568361)
20. Maes M., Mihaylova I., Kubera M., Uytterhoeven M., Vrydags N., Bosmans E., Lower plasma Coenzyme Q10 in depression: a marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness. Neuroendocrinology Letters 2009 30 4 462 469 2-s2.0-76049090965
21. Carpenter L. L., Bayat L., Moreno F., Kling M. A., Price L. H., Tyrka A. R., Kinkead B., Owens M. J., Nemeroff C. B., Decreased cerebrospinal fluid concentrations of substance P in treatment-resistant depression and lack of alteration after acute adjunct vagus nerve stimulation therapy. Psychiatry Research 2008 157 1-3 123 129 2-s2.0-36448970518 10.1016/j.psychres.2007.04.016 (Pubitemid 350167564)
22. Carvalho L. A., Garner B. A., Dew T., Fazakerley H., Pariante C. M., Antidepressants, but not antipsychotics, modulate GR function in human whole blood: an insight into molecular mechanisms. European Neuropsychopharmacology 2010 20 6 379 387 2-s2.0-77952551997 10.1016/j.euroneuro.2010.02.006
23. Juruena M. F., Pariante C. M., Papadopoulos A. S., Poon L., Lightman S., Cleare A. J., Prednisolone suppression test in depression: prospective study of the role of HPA axis dysfunction in treatment resistance. British Journal of Psychiatry 2009 194 4 342 349 2-s2.0-64149089834 10.1192/bjp.bp.108.050278
24. Watkins E., Scott J., Wingrove J., Rimes K., Bathurst N., Steiner H., Kennell-Webb S., Moulds M., Malliaris Y., Rumination-focused cognitive behaviour therapy for residual depression: a case series. Behaviour Research and Therapy 2007 45 9 2144 2154 2-s2.0-34547688947 10.1016/j.brat.2006.09.018 (Pubitemid 47210940)
25. Matsunaga M., Okamoto Y., Suzuki S. I., Kinoshita A., Yoshimura S., Yoshino A., Kunisato Y., Yamawaki S., Psychosocial functioning in patients with treatment-resistant depression after group cognitive behavioral therapy. BMC Psychiatry 2010 10, article no. 22 2-s2.0-77952530160 10.1186/1471-244X-10-22
26. Viinamäki H., Haatainen K., Honkalampi K., Tanskanen A., Koivumaa-Honkanen H., Antikainen R., Valkonen-Korhonen M., Hintikka J., Which factors are important predictors of non-recovery from major depression? A 2-year prospective observational study. Nordic Journal of Psychiatry 2006 60 5 410 416 2-s2.0-33750088420 10.1080/08039480600937801 (Pubitemid 44575520)
27. Amital D., Fostick L., Silberman A., Beckman M., Spivak B., Serious life events among resistant and non-resistant MDD patients. Journal of Affective Disorders 2008 110 3 260 264 2-s2.0-50049134985 10.1016/j.jad.2008.01.006
28. Schramm E., Schneider D., Zobel I., van Calker D., Dykierek P., Kech S., Härter M., Berger M., Efficacy of interpersonal psychotherapy plus pharmacotherapy in chronically depressed inpatients. Journal of Affective Disorders 2008 109 1-2 65 73 2-s2.0-43949099338 10.1016/j.jad.2007.10.013
29. Wiles N. J., Hollinghurst S., Mason V., Musa M., Burt V., Hyde J., Jerrom B., Lewis G., Kessler D., A randomized controlled trial of cognitive behavioural therapy as an adjunct to pharmacotherapy in primary care based patients with treatment resistant depression: a pilot study. Behavioural and Cognitive Psychotherapy 2008 36 1 21 33 2-s2.0-38149027854 10.1017/ S135246580700389X
30. Malhi G. S., Parker G. B., Crawford J., Wilhelm K., Mitchell P. B., Treatment-resistant depression: resistant to definition? Acta Psychiatrica Scandinavica 2005 112 4 302 309 2-s2.0-25644434891 10.1111/j.1600-0447.2005. 00602.x (Pubitemid 41382737)
31. Berlim M. T., Fleck M. P., Turecki G., Current trends in the assessment and somatic treatment of resistant/refractory major depression: an overview. Annals of Medicine 2008 40 2 149 159 2-s2.0-43149103165 10.1080/ 07853890701769728 (Pubitemid 351640642)
32. Keller M. B., Issues in treatment-resistant depression. The Journal of Clinical Psychiatry 2005 66, supplement 8 5 12 2-s2.0-29344462724 (Pubitemid 43004170)
33. Gaynes B. N., Davis L., Rush A. J., Trivedi M., Fava M., Wisniewski S. R., The aims and design of the sequenced treatment alternatives to relieve depression (STARD) study. Primary Psychiatry 2005 12 2 36 41 2-s2.0-14744300858 (Pubitemid 40333217)
34. Warden D., Rush A. J., Trivedi M. H., Fava M., Wisniewski S. R., The STARD project results: a comprehensive review of findings. Current Psychiatry Reports 2007 9 6 449 459 2-s2.0-37349044684 10.1007/s11920-007-0061-3 (Pubitemid 350284935)
35. Fekadu A., Wooderson S., Donaldson C., Markopoulou K., Masterson B., Poon L., Cleare A. J., A multidimensional tool to quantify treatment resistance in depression: the Maudsley staging method. The Journal of Clinical Psychiatry 2009 70 2 177 184 2-s2.0-62649147412 10.4088/JCP.08m04309
36. Rush A. J., Kilner J., Fava M., Wisniewski S. R., Warden D., Nierenberg A. A., Trivedi M. H., Clinically relevant findings from STARD. Psychiatric Annals 2008 38 3 188 193 2-s2.0-42949124131 10.3928/00485713-20080301-08
37. Patten S., Juby H., A profile of clinical depression in Canada Calgary, Canada Research Data Centre Netwo. 2008, https://dspace.ucalgary.ca/bitstream/ 1880/46327/6/PattenRSS1.pdf
38. Schwartz S., Horwitz A. V., Scheid T. L., Biological approaches to psychiatric disorders. A Handbook for the Study of Mental Health 2006 New York, NY, USA Cambridge University Press 79 102
39. Cohen C. I., The biomedicalization of psychiatry: a critical overview. Community Mental Health Journal 1993 29 6 509 521 2-s2.0-0027362276 10.1007/BF00754260 (Pubitemid 23326132)
40. Schramm E., Schneider D., Zobel I., van Calker D., Dykierek P., Kech S., Härter M., Berger M., Efficacy of interpersonal psychotherapy plus pharmacotherapy in chronically depressed inpatients. Journal of Affective Disorders 2008 109 1-2 65 73 2-s2.0-43949099338 10.1016/j.jad.2007.10.013
41. Bannan N., Multimodal therapy of treatment resistant depression: a study and analysis. International Journal of Psychiatry in Medicine 2005 35 1 27 39 2-s2.0-23044475747 10.2190/KAN6-M5HW-ADT2-P5AE (Pubitemid 41056526)
42. Parikh S. V., Lam R. W., CANMAT Depression Work Group, Clinical practice guidelines: treatment of depressive disorders. Canadian Journal of Psychiatry 2001 46, S1 5S 76S
43. Ruhé H. G., van Rooijen G., Spijker J., Peeters F. P. M. L., Schene A. H., Staging methods for treatment resistant depression. a systematic review. Journal of Affective Disorders 2011 2-s2.0-79952719220 10.1016/j.jad.2011.02.020